• Health & Medicine

Alcohol and breast cancer – how big is the risk?

A new report on breast cancer risk has made the headlines - but what does the evidence say? A new report on breast cancer risk has made the headlines - but what does the evidence say?

25 May 2017

• Science & Technology

Possible link between platelets and cancer risk, though further work needed

A possible link between cancer and the levels of a component of blood, called platelets, should be investigated further, according to a new study. A possible link between cancer and the levels of a component of blood, called platelets, should be investigated further, according to a new study.

25 May 2017

• Science & Technology
• Health & Medicine

Preventing unnecessary breast cancer treatment

Our scientists want to help doctors give women with DCIS a definitive answer on their individual risk of developing breast cancer. So they know, once and for all, if treatment is necessary. Our scientists want to help doctors give women with DCIS a definitive answer on their individual risk of developing breast cancer. So they know, once and for all, if treatment is necessary.

24 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 4

We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves. We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves.

23 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 3

We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves. We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.

22 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 2

We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves. We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.

21 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 1

We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves. We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.

20 May 2017

• Health & Medicine
• Policy & Insight

Smokers will spend around £2000 a year on cigarettes as plain, standardised packs come into full force

From today (Saturday), all tobacco products sold in the UK will come in plain standardised packaging. From today (Saturday), all tobacco products sold in the UK will come in plain standardised packaging.

20 May 2017

• Science & Technology

From finding cancers’ paper trail to harnessing the power of the Zika virus – our latest Pioneer Awards

Find out about the pioneering ideas our researchers are putting to the test, from harnessing the power of the Zika virus to finding cancer’s paper trail. Find out about the pioneering ideas our researchers are putting to the test, from harnessing the power of the Zika virus to finding cancer’s paper trail.

19 May 2017

• Science & Technology

Scientists to test Zika virus on brain tumours

In a revolutionary first, Cancer Research UK-funded scientists will test whether the Zika virus can destroy brain tumour cells. In a revolutionary first, Cancer Research UK-funded scientists will test whether the Zika virus can destroy brain tumour cells.

19 May 2017

• Health & Medicine

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China. A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

19 May 2017

• Health & Medicine

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug. Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.

17 May 2017